Kyverna's CEO on B-cell depletion and CD19 CAR-T for autoimmune conditions
- blonca9
- Mar 27, 2024
- 1 min read
Peter Maag describes how Kyverna has been focused on this area for five years and today has clinical experience in diseases as varied as lupus and multiple sclerosis.














.png)

